TY - JOUR
T1 - Association of cerebral small vessel disease burden with brain structure and cognitive and vascular risk trajectories in mid-to-late life
AU - Jansen, Michelle G.
AU - Griffanti, Ludovica
AU - Mackay, Clare E.
AU - Anatürk, Melis
AU - Melazzini, Luca
AU - Lange, Ann Marie G.de
AU - Filippini, Nicola
AU - Zsoldos, Enikő
AU - Wiegertjes, Kim
AU - Leeuw, Frank Erik de
AU - Singh-Manoux, Archana
AU - Kivimäki, Mika
AU - Ebmeier, Klaus P.
AU - Suri, Sana
N1 - Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The Whitehall II Imaging Sub-study was supported by the UK Medical Research Council (MRC) grants “Predicting MRI abnormalities with longitudinal data of the Whitehall II Sub-study” (G1001354; PI KPE; ClinicalTrials.gov Identifier: NCT03335696), and the HDH Wills 1965 Charitable Trust (Nr: 1117747, PI: K.P.E). The Whitehall II study was supported by the British Heart Foundation (RG/16/11/32334), UK Medical Research Council (R024227, S011676) and US National Institute on Aging (RF1AG062553; R01AG056477). During this study, authors were supported by: MGJ (grants from the Disciplinary Honours program of the Radboud University and Alzheimer Nederland (WE.04-2019-64)); SS (the Alzheimer’s Society Research Fellowship (grant no. 441), the Academy of Medical Sciences/the Wellcome Trust/the Government Department of Business, Energy and Industrial Strategy/the British Heart Foundation/Diabetes UK Springboard Award (SBF006\1078)). The authors also report the following funding: KPE, SS, EZs (European Commission Horizon 2020 grant “Lifebrain” (732592)); EZs (UK Medical Research Council (MRC; G1001354), HDH Wills 1965 Charitable Trust (1117747)); CEM, NF (the UK National Institute of Health Research (NIHR), Oxford Health Biomedical Research Centre (BRC)), LG (Monument Trust Discovery Award from Parkinson’s UK (J-1403), the MRC Dementias Platform UK (MR/L023784/2)); F-E.d.L (clinical established investigator grant of the Dutch Heart Foundation (grant no. 2014 T060), a VIDI innovational grant from The Netherlands Organization for Health Research and Development (ZonMw grant no. 016.126.351)), MK (UK MRC (MR/K013351/1, MR/R024227/1, MR/S011676/1), National Institute on Aging (NIH), US (R01AG056477), NordForsk (75021), Academy of Finland (311492), Helsinki Institute of Life Science Fellowship (H970))), ASM (National Institute of Health (RF1AG062553; R01AG056477)), AMGdL (the Norwegian Research Council (286838)). The Wellcome Centre for Integrative Neuroimaging (WIN) is supported by core funding from the Wellcome Trust (203139/Z/16/Z). For the purpose of open access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. Acknowledgments
Publisher Copyright:
© The Author(s) 2021.
PY - 2021
Y1 - 2021
N2 - We characterize the associations of total cerebral small vessel disease (SVD) burden with brain structure, trajectories of vascular risk factors, and cognitive functions in mid-to-late life. Participants were 623 community-dwelling adults from the Whitehall II Imaging Sub-study with multi-modal MRI (mean age 69.96, SD = 5.18, 79% men). We used linear mixed-effects models to investigate associations of SVD burden with up to 25-year retrospective trajectories of vascular risk and cognitive performance. General linear modelling was used to investigate concurrent associations with grey matter (GM) density and white matter (WM) microstructure, and whether these associations were modified by cognitive status (Montreal Cognitive Asessment [MoCA] scores of < 26 vs. ≥ 26). Severe SVD burden in older age was associated with higher mean arterial pressure throughout midlife (β = 3.36, 95% CI [0.42-6.30]), and faster cognitive decline in letter fluency (β = −0.07, 95% CI [−0.13–−0.01]), and verbal reasoning (β = −0.05, 95% CI [−0.11–−0.001]). Moreover, SVD burden was related to lower GM volumes in 9.7% of total GM, and widespread WM microstructural decline (FWE-corrected p < 0.05). The latter association was most pronounced in individuals who demonstrated cognitive impairments on MoCA (MoCA < 26; F3,608 = 2.14, p = 0.007). These findings highlight the importance of managing midlife vascular health to preserve brain structure and cognitive function in old age.
AB - We characterize the associations of total cerebral small vessel disease (SVD) burden with brain structure, trajectories of vascular risk factors, and cognitive functions in mid-to-late life. Participants were 623 community-dwelling adults from the Whitehall II Imaging Sub-study with multi-modal MRI (mean age 69.96, SD = 5.18, 79% men). We used linear mixed-effects models to investigate associations of SVD burden with up to 25-year retrospective trajectories of vascular risk and cognitive performance. General linear modelling was used to investigate concurrent associations with grey matter (GM) density and white matter (WM) microstructure, and whether these associations were modified by cognitive status (Montreal Cognitive Asessment [MoCA] scores of < 26 vs. ≥ 26). Severe SVD burden in older age was associated with higher mean arterial pressure throughout midlife (β = 3.36, 95% CI [0.42-6.30]), and faster cognitive decline in letter fluency (β = −0.07, 95% CI [−0.13–−0.01]), and verbal reasoning (β = −0.05, 95% CI [−0.11–−0.001]). Moreover, SVD burden was related to lower GM volumes in 9.7% of total GM, and widespread WM microstructural decline (FWE-corrected p < 0.05). The latter association was most pronounced in individuals who demonstrated cognitive impairments on MoCA (MoCA < 26; F3,608 = 2.14, p = 0.007). These findings highlight the importance of managing midlife vascular health to preserve brain structure and cognitive function in old age.
KW - Ageing
KW - cardiovascular risk
KW - cognition
KW - magnetic resonance imaging
KW - small vessel disease
UR - http://www.scopus.com/inward/record.url?scp=85116573283&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85116573283&partnerID=8YFLogxK
U2 - 10.1177/0271678X211048411
DO - 10.1177/0271678X211048411
M3 - Article
AN - SCOPUS:85116573283
JO - Journal of Cerebral Blood Flow and Metabolism
JF - Journal of Cerebral Blood Flow and Metabolism
SN - 0271-678X
ER -